207 related articles for article (PubMed ID: 6322723)
1. The effect of chemotherapy on hepatoblastoma.
Forouhar FA; Quinn JJ; Cooke R; Foster JH
Arch Pathol Lab Med; 1984 Apr; 108(4):311-4. PubMed ID: 6322723
[TBL] [Abstract][Full Text] [Related]
2. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
3. [Therapy of malignant liver tumors in childhood. An intermediate report of the HB-89 multicenter study of the GPOH].
von Schweinitz D; Bürger D; Weinel P; Mildenberger H
Klin Padiatr; 1992; 204(4):214-20. PubMed ID: 1381454
[TBL] [Abstract][Full Text] [Related]
4. Resection after intraarterial chemotherapy of a hepatoblastoma originating in the caudate lobe.
Takayama T; Makuuchi M; Takayasu K; LeThai B; Ohyama H; Yamazaki S; Hasegawa H
Surgery; 1990 Feb; 107(2):231-5. PubMed ID: 2154056
[TBL] [Abstract][Full Text] [Related]
5. [Combination chemotherapy and chemoembolization in the treatment of primary inoperable hepatoblastoma].
Berthold F; Schultheis KH; Aigner K; Lampert F
Klin Padiatr; 1986; 198(3):257-61. PubMed ID: 2425123
[TBL] [Abstract][Full Text] [Related]
6. Preoperative chemoembolization for unresectable hepatoblastoma.
Tashjian DB; Moriarty KP; Courtney RA; Bean MS; Steele DA
Pediatr Surg Int; 2002 Mar; 18(2-3):187-9. PubMed ID: 11956795
[TBL] [Abstract][Full Text] [Related]
7. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
[TBL] [Abstract][Full Text] [Related]
8. Fibrolamellar hepatocellular carcinoma in children and adolescents.
Katzenstein HM; Krailo MD; Malogolowkin MH; Ortega JA; Qu W; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Newman K; Finegold MJ; Haas JE; Sensel MG; Castleberry RP; Bowman LC
Cancer; 2003 Apr; 97(8):2006-12. PubMed ID: 12673731
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
Perilongo G; Maibach R; Shafford E; Brugieres L; Brock P; Morland B; de Camargo B; Zsiros J; Roebuck D; Zimmermann A; Aronson D; Childs M; Widing E; Laithier V; Plaschkes J; Pritchard J; Scopinaro M; MacKinlay G; Czauderna P
N Engl J Med; 2009 Oct; 361(17):1662-70. PubMed ID: 19846851
[TBL] [Abstract][Full Text] [Related]
10. [Systemic chemotherapy of hepatocellular carcinoma].
Okazaki N; Yoshino M; Yoshida T; Hizikata A; Hasegawa H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1584-8. PubMed ID: 3015033
[TBL] [Abstract][Full Text] [Related]
11. Adriamycin and cisplatin for hepatoblastoma.
Quinn JJ; Altman AJ; Robinson HT; Cooke RW; Hight DW; Foster JH
Cancer; 1985 Oct; 56(8):1926-9. PubMed ID: 2411381
[TBL] [Abstract][Full Text] [Related]
12. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children.
Li JP; Chu JP; Yang JY; Chen W; Wang Y; Huang YH
Cardiovasc Intervent Radiol; 2008; 31(6):1117-23. PubMed ID: 18560935
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of doxorubicin and cisplatin in patients with metastatic hepatocellular carcinoma.
Lee J; Park JO; Kim WS; Park SH; Park KW; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Joh J; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Park K
Cancer Chemother Pharmacol; 2004 Nov; 54(5):385-90. PubMed ID: 15248028
[TBL] [Abstract][Full Text] [Related]
14. Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.
Ortega JA; Krailo MD; Haas JE; King DR; Ablin AR; Quinn JJ; Feusner J; Campbell JR; Lloyd DA; Cherlow J
J Clin Oncol; 1991 Dec; 9(12):2167-76. PubMed ID: 1720452
[TBL] [Abstract][Full Text] [Related]
15. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
Casanova M; Massimino M; Ferrari A; Spreafico F; Piva L; Coppa J; Luksch R; Cefalo G; Terenziani M; Polastri D; Bellani FF; Mazzaferro V
Pediatr Hematol Oncol; 2005; 22(3):189-98. PubMed ID: 16020101
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy combined with surgery in successful treatment of hepatoblastoma.
Borger JA; Barbosa JL; Lehan CA
J Fla Med Assoc; 1989 Dec; 76(12):1023-6. PubMed ID: 2557375
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of doxorubicin and cisplatin resistant hepatoblastoma in a child with Beckwith-Wiedemann syndrome with high dose acetaminophen and N-acetylcysteine rescue.
Kobrinsky NL; Sjolander DE; Goldenberg JA; Ortmeier TC
Pediatr Blood Cancer; 2005 Aug; 45(2):222-5. PubMed ID: 15770640
[TBL] [Abstract][Full Text] [Related]
18. [Primary and secondary inoperable teratoid hepatoblastoma--multidisciplinary management].
Lackner H; Urban C; Sauer H; Lammer J; Pakisch B; Kaulfersch W; Gamillscheg A; Slavc I; Riccabona M; Klos I
Padiatr Padol; 1990; 25(5):299-312. PubMed ID: 1705020
[TBL] [Abstract][Full Text] [Related]
19. Hepatoblastoma: the Indiana experience with preoperative chemotherapy for inoperable tumors; clinicopathological considerations.
Heifetz SA; French M; Correa M; Grosfeld JL
Pediatr Pathol Lab Med; 1997; 17(6):857-74. PubMed ID: 9353826
[TBL] [Abstract][Full Text] [Related]
20. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]